Skip to main navigation

Investor Relations

  • Who We Are
    • Management
    • Board of Directors
  • Our Focus
    • Dismutase Mimetics
    • Reducing Oral Mucositis
    • Aiming to Increase Efficacy of Radiation Therapy
  • Our Pipeline
    • Avasopasem (GC4419)
    • Rucosopasem (GC4711)
    • Clinical Trials
    • Key Publications
  • Investors
    • IR Home
    • Press Releases
    • Events and Presentations
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Shareholder Services
  • Contact Us

Press Releases

Press Releases
Dec 12, 2022
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
View HTML
PDF Version
Nov 22, 2022
Galera to Present at Piper Sandler Annual Healthcare Conference
View HTML
PDF Version
Nov 09, 2022
Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
View HTML
PDF Version
Oct 26, 2022
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
View HTML
PDF Version
Sep 26, 2022
Galera to Present at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
View HTML
PDF Version
Sep 06, 2022
Galera to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
View HTML
PDF Version
Sep 01, 2022
Galera Appoints Eugene P. Kennedy, M.D., F.A.C.S., as Chief Medical Officer
View HTML
PDF Version
Aug 09, 2022
Galera Reports Second Quarter 2022 Financial Results and Recent Corporate Updates
View HTML
PDF Version
Jun 29, 2022
Galera Announces Results from Phase 1 Stage of GRECO-1 Trial of Rucosopasem with SBRT for NSCLC
View HTML
PDF Version
Jun 02, 2022
Galera to Present at Jefferies Healthcare Conference
View HTML
PDF Version

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 17 results

Investor Relations - Horizontal

IR Home
Press Releases
Events and Presentations
Stock Information
Corporate Governance
SEC Filings
Shareholder Services

Tools

Day High:
Day Low:
Volume:
Jan 14, 2023 1:03 PM EST

Data Provided by Refinitiv.
Minimum 15 minutes delayed.

© Copyright 2023 Galera Therapeutics
Website Design & Development Graphic Beans
Privacy Policy – Terms of Use – Compassionate Use Policy

LinkedIn